Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers

<p>Aims: Ventricular arrhythmia triggers sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM), yet electrophysiological biomarkers are not used for risk stratification. Our aim was to identify distinct HCM phenotypes based on ECG computational analysis, and characterize differences...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Lyon, A, Ariga, R, Minchole, A, Mahmod, M, Ormondroyd, E, Laguna, P, de Freitas, N, Neubauer, S, Watkins, H, Rodriguez, B
Formato:	Journal article
Publicado em:	Frontiers Media 2018

Registros relacionados

Risk stratification in hypertrophic cardiomyopathy based on QRS and T wave morphological biomarkers identifies three phenotypic subgroups
por: Lyon, A, et al.
Publicado em: (2016)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
por: Chow, J, et al.
Publicado em: (2024)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
por: Ji-Jian Chow, et al.
Publicado em: (2024-08-01)

Electrocardiogram phenotypes in hypertrophic cardiomyopathy caused by distinct mechanisms: apico-basal repolarization gradients vs. Purkinje-myocardial coupling abnormalities
por: Lyon, A, et al.
Publicado em: (2018)

Extraction of morphological QRS-based biomarkers in hypertrophic cardiomyopathy for risk stratification using L1 regularized logistic regression
por: Lyon, A, et al.
Publicado em: (2016)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
por: Passini, E, et al.
Publicado em: (2015)

Bridging the Gap Between ECG Indicators of Arrhythmic Risk and the Continuum of Myocardial Disarray and Fibrosis Across Hypertrophic Cardiomyopathy Stages
por: Zakariye Ashkir, MD, et al.
Publicado em: (2024-01-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
por: Coleman, JA, et al.
Publicado em: (2024)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
por: James A. Coleman, et al.
Publicado em: (2024-04-01)

ECG-based estimation of dispersion of APD restitution as a tool to stratify sotalol-induced arrhythmic risk.
por: Mincholé, A, et al.
Publicado em: (2015)

Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy
por: Coleman, JA
Publicado em: (2024)

Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy
por: Masliza Mahmod, et al.
Publicado em: (2022-06-01)

Imaging Predictors of Arrhythmic Risk in Genotyped Hypertrophic Cardiomyopathy Patients
por: Safa Daghem, et al.
Publicado em: (2024-01-01)

ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY
por: S. M. Komissarova, et al.
Publicado em: (2021-05-01)

Non-invasive imaging of myocardial disarray associates with ventricular arrhythmia in hypertrophic cardiomyopathy
por: Ariga, R, et al.
Publicado em: (2017)

Diffusion tensor magnetic resonance imaging of myocardial disarray in hypertrophic cardiomyopathy
por: Ariga, R, et al.
Publicado em: (2018)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
por: Ariga, R, et al.
Publicado em: (2019)

Files associated with: "Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy"
por: Coleman, J
Publicado em: (2024)

Pseudo-arrhythmic ECG artifact
por: Satyajeet Singh, et al.
Publicado em: (2012-01-01)

The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy
por: Sílvia Aguiar Rosa, et al.
Publicado em: (2021-12-01)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
por: Neubauer, S, et al.
Publicado em: (2019)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
por: Blair, E, et al.
Publicado em: (2003)

Distinct Phenotypic Groups and Related Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy
por: Soongu Kwak, et al.
Publicado em: (2024-10-01)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry
por: Neubauer, S, et al.
Publicado em: (2019)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
por: Hudsmith, L, et al.
Publicado em: (2006)

Pro-arrhythmic Electrophysiological Abnormalities in Subclinical and Overt Hypertrophic Cardiomyopathy; Insights from CMR-ECGI
por: George Joy, MD, et al.
Publicado em: (2024-01-01)

Discrepancy between pathological progression and clinical stability in a young patient with hypertrophic cardiomyopathy
por: Raman, B, et al.
Publicado em: (2018)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
por: Raman, B, et al.
Publicado em: (2018)

Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study
por: Lyon, A, et al.
Publicado em: (2019)

Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
por: Raman, B, et al.
Publicado em: (2021)

Computational techniques for ECG analysis and interpretation in light of their contribution to medical advances
por: Lyon, A, et al.
Publicado em: (2018)

Restrictive cardiomyopathy and hypertrophic cardiomyopathy overlap: the importance of the phenotype
por: Juan Pablo Kaski, et al.
Publicado em: (2012-10-01)

Sudden death in hypertrophic cardiomyopathy.
por: Watkins, H
Publicado em: (2000)

Impaired left ventricular energy metabolism in hypertrophic cardiomyopathy is not due to fibrosis.
por: Petersen, SE, et al.
Publicado em: (2009)

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
por: Doste, R, et al.
Publicado em: (2022)

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy
por: Coleman, J, et al.
Publicado em: (2023)

Atypical ECG Presentation of Hypertrophic Cardiomyopathy stimulating Acute Myocardial Infarction
por: Rikesh Tamrakar
Publicado em: (2021-04-01)

Adenosine stress T1 mapping: a novel contrast free method to assess myocardial perfusion and ischaemia in hypertrophic cardiomyopathy
por: Raman, B, et al.
Publicado em: (2017)

A Genotype-phenotype Taxonomy of Hypertrophic Cardiomyopathy
por: Lara Curran, BSc, et al.
Publicado em: (2024-01-01)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
por: Blair, E, et al.
Publicado em: (2001)